ReviewMyocardial Infarction in the “Young”: Risk Factors, Presentation, Management and Prognosis
Introduction
The leading cause of death in the world is coronary heart disease (CHD) [1] and while there is a large body of data available for CHD, literature focussing on premature CHD and myocardial infarction (MI) in the “young” is lacking. Consequences of MI can be devastating particularly at a “young” age due to its greater potential impact on the patient's psychology, ability to work and the socioeconomic burden. As “young” MI patients may be the main income producer of the family, the aftermath of MI can also affect multiple dependents. Clinicians may not appreciate the differences that exist between “young” and older MI patients.
In this paper we report the differences in rate, risk factor profile, presentation, management and prognosis between “young” and older MI patients.
Section snippets
Methods
A literature search was conducted via MEDLINE and GOOGLE for the years between 1980 and 2015 using the keywords “young” and “myocardial infarction”. The search was restricted to papers published in the English language and in peer-reviewed journals.
Definition and Epidemiology
There is disparity in the literature on the definition of “young” with respect to premature CHD and MI. The term “young” varies from ≤40 [2], [3], [4] to ≤55 years of age [5]. Others have suggested 45 years as a cut-off when defining “young” with respect to MI [6], [7], [8]. As there is no universally accepted age cut-off, this review will not use a single definition but rather will accept the cut-off or range used by the authors of the data being reviewed.
There is a paucity of data on MI in
Risk Factors
The extent of relative risk for future events of traditional cardiovascular risk factors are comparable in “young” and older adults [16]. The majority of patients suffering MI at a “young” age are reported to have at least one identifiable cardiovascular risk factor [6], [17], [18], [19]. Hoit et al. reported a higher prevalence of smoking, family history of premature CHD and male gender among “young” MI patients compared with their older counterparts [6]. Others have supported this finding
Clinical Presentation and Angiographic Findings
Up to two-thirds of “young” MI patients will present with non-ST elevation myocardial infarction (NSTEMI) with approximately a third presenting with STEMI [10]. It appears that, overall, the incidence of STEMI is reducing among the “young” but the proportion of “young” patients diagnosed with STEMI is increasing [10]. Most “young” MI patients do not report a history of previous angina, MI or congestive heart failure and they report this less frequently in their histories than their older
Management
The management of MI generally is not dependent on age and guideline-suggested therapies are just as applicable to younger patients as they are to their older counterparts [44], [45]. With respect to STEMI management, the benefits of primary angioplasty over thrombolysis are as applicable in “young” patients as they are in older individuals and no particular age cohort has a greater relative benefit [46]. “Young” age is an independent predictor for favourable prognosis following thrombolysis
Prognosis
In-hospital and short-term outcomes are generally favourable in “young” MI patients. In-hospital and six-month mortality has been shown to be 0.7% and 3.1%, respectively [21]. This compares favourably to their older counterparts whose in-hospital and six-month mortality were 8.3% and 12%, respectively [21]. Beyond five years post-MI, however, there is an alarming drop in survival among “young” MI patients with mortality exceeding 15% at seven years [20] and being between 25-29% at 15 years [5],
Summary
The incidence of MI in “young” patients is substantial. Smoking remains one of the most important risk factors and should be the target of any program aimed to reduce the rate of MI in the “young”. “Young” MI patients often lack warning symptoms of escalating chest pain. Coronary angiography in the “young” tends to reveal less extensive disease in comparison with their older counterparts and hence they are more often managed with percutaneous revascularisation. Short-term outcomes post-MI at a
Funding
Supported by the Western Health Research Grant 2013.
Conflict of Interest
The authors report no relationships that could be construed as a conflict of interest.
References (59)
- et al.
Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age
J Am Coll Cardiol.
(1994) - et al.
Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction
Am J Cardiol.
(2011) - et al.
Acute myocardial infarction in the young--The University of Michigan experience
Am Heart J
(2002) - et al.
Comparison of thrombolytic therapy for acute myocardial infarction in patients aged < 35 and > 55 years
Am J Cardiol.
(1993) - et al.
Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry)
J Am Coll Cardiol
(1995) - et al.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Lancet
(2004) - et al.
Circadian variation of acute myocardial infarction in young people
Am J Emerg Med.
(2012) - et al.
Association of obesity with risk of coronary heart disease: findings from the National Health and Nutrition Examination Survey, 1999-2006
Surg Obes Relat Dis.
(2010) - et al.
Socioeconomic indicators and the risk of acute coronary heart disease events: comparison of population-based data from the United States and Finland
Ann Epidemiol.
(2011) - et al.
Outcomes following conservative management of spontaneous coronary artery dissection
Heart Lung Circ.
(2014)
Sequelae of Kawasaki disease in adolescents and young adults
J Am Coll Cardiol.
Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women
Am J Med.
Effect of age on outcome with primary angioplasty versus thrombolysis
J Am Coll Cardiol.
Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome)
JACC Cardiovasc Interv.
Coronary anatomy and prognosis of young, asymptomatic survivors of myocardial infarction
Am J Med.
Smoking cessation after acute myocardial infarction
J Am Coll Cardiol.
Long-term prognosis of patients having acute myocardial infarction when </=40 years of age
Am J Cardiol.
Angina frequency after myocardial infarction and quality of life in older versus younger adults: the Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study
Am Heart J.
A retrospective case-control study of modifiable risk factors and cutaneous markers in Indian patients with young coronary artery disease
JRSM Cardiovasc Dis.
Fasting plasma homocysteine levels are increased in young patients with acute myocardial infarction from Western India
Indian Heart J.
Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age)
Eur Heart J.
A prospective study of long term prognosis in young myocardial infarction survivors: the prognostic value of angiography and exercise testing
Heart
Myocardial infarction in young patients: an analysis by age subsets
Circulation
Impact of risk factors for non-fatal acute myocardial infarction
Eur J Epidemiol.
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study
N Engl J Med.
Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth
Circulation
Myocardial infarction in men aged 40 years or less: a prospective clinical-angiographic study
Clin Cardiol.
Demographic, seasonal, and spatial differences in acute myocardial infarction admissions to hospital in Melbourne Australia
Int J Health Geogr.
Cited by (90)
Characteristics and Outcomes of Young Patients With ST-Elevation Myocardial Infarction Without Standard Modifiable Risk Factors
2023, American Journal of CardiologyImpact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)
2023, American Journal of CardiologyCitation Excerpt :Conversely, we found a higher rate of any revascularization in younger patients from 5- to 10-year follow-up but not in the first 5 years after the index primary PCI, with a similar trend for any myocardial infarction. This late occurrence of adverse events could be explained by an important genetic load for cardiovascular disease.29,30 It is important to highlight that this higher incidence of revascularization in the young patients was driven by both target vessel and nontarget revascularization, with a slight predominance of target vessel-related events.